A breakthrough in treating an aggressive form of prostate cancer could boost survival rates, according to new research.

Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

Research found that the weight-loss medications may reduce the spread of several obesity-related cancers, including lung, ...

Routine prostate cancer screening has been rejected by the UK's independent screening committee despite significant pressure ...

Ceramides-lipid molecules in cells that affect many physiological functions including cell differentiation, migration, and ...

Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...

Prostate cancer is the most commonly diagnosed cancer in the UK, with more than 63,000 new cases each year. Yet for many men, understanding their treatment options remains far from straightforward ...

The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Today, a patient diagnosed with advanced prostate cancer has options. Doctors can offer a suite of androgen-suppressing drugs to extend his life. There are genetic tests that can show whether he’s a ...

The UK's National Screening Committee has concluded its review of prostate cancer screening in the UK, saying that the harms of a large-scale, national programme would outweigh the benefits. The ...

UK experts have recommended that only a small group of high-risk men should be eligible for regular testing for prostate ...